2 completed, 2 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Terminated 1 |
Follow Pregnancy test: new trials by email Literature Review of Pregnancy test trials Research Report on Pregnancy test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests - NSCLC | Phase 2 | Recruiting | Groupe Francais De Pneumo-Cancerologie | 45 | 2025-06-19 | 2026-04-29 |
| Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants ICF, Eligibility Assessment, Demographic data - HIV, HIV Infection | Phase 2 | Recruiting | Code Pharma | 40 | 2023-07-20 | 2024-11-06 |
| Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) Baricitinib, pharmacokinetics study, dosage of cytokines - Juvenile Dermatomyositis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2022-11-10 | 2026-04-23 |
| Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 Biochemistry blood test, Hematology blood test, D-Dimer test (coagulation) - Covid19, Corona Virus Infection | Phase 2 | Completed | MGC Pharmaceuticals d.o.o | 240 | 2022-10-11 | 2023-03-15 |
| Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY JNJ-56022473, Bone marrow analyses and CBC with differential, Flow cytometry analyses - Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | Phase 2 | Terminated | GWT-TUD GmbH | 25 | 2016-07-01 | 2018-10-25 |
Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Coronavirus Infections (1) · Dermatomyositis (1) · HIV Infections (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Myelodysplastic Syndromes (1)
Assistance Publique - Hôpitaux de Paris (1) · Code Pharma (1) · GWT-TUD GmbH (1) · Groupe Francais De Pneumo-Cancerologie (1) · MGC Pharmaceuticals d.o.o (1)
France (3) · Brazil (1) · Germany (1) · Israel (1)
Rita Nadaf (1) · Uwe Platzbecker, Prof. (1)